$Recursion Pharmaceuticals, In

RXRX

12-03 04:59

USRecursion Pharmaceuticals, Inc.

Side	Price \| Filled	Realized P&L
Sell Close	4.32 100	-13.96% Closed

Recursion Pharmaceuticals, Inc.

Trade Feed: Who is your favorite trader?

Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the "hidden gem traders" that you've discovered!

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Trade Feed Decoder
12-03
Trade Feed Decoder
Analysis of RXRX Trade: The SELL execution at $4.32 resulted in a 13.96% loss, indicating potential challenges in timing or thesis validation for this biotech stock. Given RXRX's volatility (52-week range: $7.76-$2.40), the exit might reflect risk management amid sector-specific uncertainties common in clinical-stage pharma companies. The realized loss suggests either a stop-loss trigger or repositioning given changing fundamentals. Traders should note that biotech stocks often face binary outcomes tied to trial results or funding news. While the rationale isn't specified, this trade underscores the importance of defined exit strategies in speculative sectors. The negative P&L percentage highlights the risk-reward balance inherent in pre-revenue biotech investments, where position sizing becomes critical to manage downside exposure.

Leave a comment

{"i18n":{"language":"en_US"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":506623604650424,"tweetId":"506623604650424","gmtCreate":1764709209728,"gmtModify":1764709212086,"author":{"id":4109843165472380,"idStr":"4109843165472380","authorId":4109843165472380,"authorIdStr":"4109843165472380","name":"Mic6226","avatar":"https://community-static.tradeup.com/news/642ea3ba3ea408756b94df1fc4fc2d69","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":12,"crmLevelSwitch":1,"currentWearingBadge":{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.06.28","exceedPercentage":"93.03%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":54,"starInvestorFlag":true,"fullDisclosureFlag":true,"starInvestorFollowerNum":25,"starInvestorOrderShareNum":196,"userFollowInvestorFlag":false,"orderNotificationFlag":false,"ror":-24.61,"showRor":true,"winRationPercentage":72.114137,"tradeVolumeEst":0},"themes":[{"themeId":"4e1ab37448a24dd39b7882426fc6fd27","categoryId":"ab3d937a5fd848c08008411a9be702b5","name":"Trade Feed: Who is your favorite trader?","type":0,"rnLink":"https://laohu8.com/RN?name=RNTheme&page=/theme/detail&rndata={\"themeId\":4e1ab37448a24dd39b7882426fc6fd27}&rnconfig={\"headerBarHidden\": true}","description":"Come to the Trade Feed Topic to find more trading opportunities! Also, please feel free to recommend and introduce fellow Tigers to the \"hidden gem traders\" that you've discovered!","image":"https://community-static.tradeup.com/news/e496e574dd744490c7b4f7959f83f5a4"}],"images":[],"coverImages":[],"html":"<html><head></head><body><a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a><a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","htmlText":"<html><head></head><body><a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a><a href=\"https://ttm.financial/U/10000000000011061\">@Trade Feed Decoder</a></body></html>","text":"$Recursion Pharmaceuticals, Inc.(RXRX)$ @Trade Feed Decoder","highlighted":1,"essential":1,"paper":1,"likeSize":27,"commentSize":1,"repostSize":16,"favoriteSize":0,"link":"https://ttm.financial/post/506623604650424","repostId":0,"isVote":1,"tweetType":1,"viewCount":818,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["RXRX"],"verified":2,"subType":0,"readableState":1,"langContent":"EN","currentLanguage":"EN","warmUpFlag":false,"orderFlag":true,"orderData":{"uuid":"4109843165472380","orderId":"41393843496553472","kind":"TRADE","symbol":"RXRX","secType":"STK","symbolHtmlTag":"<a href=\"https://ttm.financial/S/RXRX\">$Recursion Pharmaceuticals, Inc.(RXRX)$&nbsp;</a>","symbolHtmlTagHref":"https://ttm.financial/S/RXRX","symbolName":"Recursion Pharmaceuticals, Inc.","market":"US","action":"SELL","currency":"USD","symbolLogo":"","showFilledQuantity":true,"nameCN":"Recursion Pharmaceuticals, Inc.","orderType":"LMT","filledQuantityFinal":100,"avgFillPrice":4.32,"createTime":1764709163,"filledQuantity":"100","filledQuantityScale":"0","openFlag":false,"side":"DEBIT","contractMajorDescription":"Recursion Pharmaceuticals, Inc.","contractExtraDescription":"RXRX","legs":[],"completedFlag":true,"orderPnl":{"realizedPnlPercent":-0.1396,"realizedPnlByAveragePercent":-0.1396},"quickOrderFlag":false},"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":["订单分享帖","未分享订单分享帖"],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":17,"optionInvolvedFlag":false,"xxTargetLangEnum":"ORIG"},"commentList":[{"id":506648360153440,"commentId":"506648360153440","gmtCreate":1764715233077,"gmtModify":1764725735528,"authorId":10000000000011060,"author":{"id":10000000000011060,"idStr":"10000000000011061","authorId":10000000000011060,"name":"Trade Feed Decoder","avatar":"https://community-static.tradeup.com/news/4dc8fec78bad5acffbf563bdbc6bc8ed","vip":4,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":506623604650424,"objectIdStr":"506623604650424","type":1,"supId":0,"supIdStr":"0","prevId":0,"prevIdStr":"0","content":"Analysis of RXRX Trade: The SELL execution at $4.32 resulted in a 13.96% loss, indicating potential challenges in timing or thesis validation for this biotech stock. Given RXRX's volatility (52-week range: $7.76-$2.40), the exit might reflect risk management amid sector-specific uncertainties common in clinical-stage pharma companies. The realized loss suggests either a stop-loss trigger or repositioning given changing fundamentals. Traders should note that biotech stocks often face binary outcomes tied to trial results or funding news. While the rationale isn't specified, this trade underscores the importance of defined exit strategies in speculative sectors. The negative P&amp;L percentage highlights the risk-reward balance inherent in pre-revenue biotech investments, where position sizing becomes critical to manage downside exposure.","text":"Analysis of RXRX Trade: The SELL execution at $4.32 resulted in a 13.96% loss, indicating potential challenges in timing or thesis validation for this biotech stock. Given RXRX's volatility (52-week range: $7.76-$2.40), the exit might reflect risk management amid sector-specific uncertainties common in clinical-stage pharma companies. The realized loss suggests either a stop-loss trigger or repositioning given changing fundamentals. Traders should note that biotech stocks often face binary outcomes tied to trial results or funding news. While the rationale isn't specified, this trade underscores the importance of defined exit strategies in speculative sectors. The negative P&amp;L percentage highlights the risk-reward balance inherent in pre-revenue biotech investments, where position sizing becomes critical to manage downside exposure.","html":"Analysis of RXRX Trade: The SELL execution at $4.32 resulted in a 13.96% loss, indicating potential challenges in timing or thesis validation for this biotech stock. Given RXRX's volatility (52-week range: $7.76-$2.40), the exit might reflect risk management amid sector-specific uncertainties common in clinical-stage pharma companies. The realized loss suggests either a stop-loss trigger or repositioning given changing fundamentals. Traders should note that biotech stocks often face binary outcomes tied to trial results or funding news. While the rationale isn't specified, this trade underscores the importance of defined exit strategies in speculative sectors. The negative P&amp;L percentage highlights the risk-reward balance inherent in pre-revenue biotech investments, where position sizing becomes critical to manage downside exposure.","likeSize":0,"commentSize":0,"subComments":[],"verified":10,"allocateAmount":0,"commentType":"hot","coins":0,"score":0,"disclaimerFlag":true,"disclaimerType":1,"specialCommentTag":"AI_ANALYSE"}],"isCommentEnd":false,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/506623604650424"}